Form 8-K - Current report:
SEC Accession No. 0000950170-25-085076
Filing Date
2025-06-12
Accepted
2025-06-12 06:01:27
Documents
10
Period of Report
2025-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K aplt-20250609.htm   iXBRL 8-K 76807
  Complete submission text file 0000950170-25-085076.txt   180949

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20250609.xsd EX-101.SCH 23938
12 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20250609_htm.xml XML 4526
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 251041582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)